Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor

FCPA Blog Daily News

Entries in GlaxoSmithKline (37)


Reports: GSK fired China staff in 2001 for bribes

Press reports that GlaxoSmithKline fired employees of its China unit in 2001 for paying bribes to government officials could complicate the company's defense of current allegations about illegal sales practices in several countries.

Click to read more ...


GSK-linked investigators formally charged in Shanghai court

Prosecutors in China have filed formal charges against British private investigator Peter Humphrey and his American wife, the state-controlled Xinhua news agency said Monday.

Click to read more ...


Report: GSK-linked Peter Humphrey facing secret China trial

The trial of a British corporate investigator and his American wife who once worked with GlaxoSmithKline will be closed to the public and foreign consular officials, the South China Morning Post reported Thursday.

Click to read more ...


SFO launches criminal probe of GSK

GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.

Click to read more ...


Chinese police charge former GSK China chief Mark Reilly

Chinese police Wednesday charged the British former boss of GlaxoSmithKline's China unit and two other company executives with corruption for bribing health officials and doctors.

Click to read more ...


GSK confirms Jordan, Lebanon bribe probes

GlaxoSmithKline said it is investigating allegations of bribery in Jordan and Lebanon first reported by the media.

Click to read more ...


GSK cuts 150 China staff for improper sales practices 

UK drug maker GlaxoSmithKline (GSK) has sacked over 150 staff in China amid a probe into allegations that the firm bribed doctors and government officials to boost drug sales, according to the 21st Century Business Herald (21CBH).

Click to read more ...


GSK accused of bribing doctors in Poland

Sir Andrew Witty, CEO of GlaxoSmithKline, courtesy of Wellcome Trust via YouTubeGlaxoSmithKline is facing a criminal investigation in Poland for allegedly bribing doctors there between 2010 and 2012.

Click to read more ...


Job: Investigator, Asia (FCPA investigations)

Job Title:  Investigator, Asia (FCPA investigations)

Employer:  GlaxoSmithKline plc

Location: Karnataka, Bangalore, India

Click to read more ...


GSK probes Iraq sales

British pharma GlaxoSmithKline said it is investigating allegations the company hired government-employed doctors and pharmacists in Iraq as paid sales reps for its products.

Click to read more ...


Job: Wellness R&D Operations Manager, Compliance

Job Title: Wellness R&D Operations Manager, Compliance

Employer: GlaxoSmithKline plc

Location: Parsippany, New Jersey, USA

Click to read more ...


China Corruption Blotter (January 13, 2014)

Huang Fengping, deputy director of the Shanghai Municipal Commission of Health and Family Planning, has been suspended and placed under investigation on suspicion of accepting bribes during drug procurements for Shanghai’s Huashan Hospital. He has also been implicated in GlaxoSmithKline's (GSK) bribery investigation in China. One of Huang's relatives worked for GSK China.

Click to read more ...